Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Pembrolizumab Shows Promise as Adjuvant Therapy in Resected Stage IB-IIIA NSCLC Jun 08, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Cost-Effectiveness of Adjuvant Atezolizumab in Early-Stage PD-L1 Overexpressing NSCLC Jun 08, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Durvalumab ± Tremelimumab + Chemo in First-Line Metastatic NSCLC: POSEIDON Study Jun 08, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) FDA Approval Summary: Nivolumab Plus Chemo for Neoadjuvant Treatment in Resectable NSCLC Jun 08, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Tiragolumab and atezolizumab as 1L therapy for PD-L1-selected NSCLC Jun 02, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Analyzing Asian Patients in VISION Trial: Tepotinib for METex14 Skipping NSCLC Jun 01, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Toripalimab vs. Placebo in Advanced NSCLC: Survival and Biomarker Analysis from CHOICE-01 Jun 01, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Molecular Profiling Study of EGFR-Mutated NSCLC Patients Treated With 1L Osimertinib Jun 01, 2023
